feed,title,long_url,short_url
MarketWatch,Enlivex stock soars to lead premarket gainers after getting OK to start Phase 2b trial of COVID-19 treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/2kysAc4KLL8/story.aspx,https://on.mktw.net/3iPCZ2n
